Calumet, Inc. (NASDAQ:CLMT – Get Free Report) hit a new 52-week high during trading on Tuesday . The stock traded as high as $51.57 and last traded at $51.52, with a volume of 2014355 shares traded. The stock had previously closed at $49.73.
Calumet News Summary
Here are the key news stories impacting Calumet this week:
- Positive Sentiment: HC Wainwright raised its Q3 2026 EPS forecast to $0.62 from $0.60 and its Q4 forecast to $0.24 from $0.22. The firm maintained a Buy rating and lifted its price target to $75 from $60, implying approximately 41% upside from the referenced share price. HC Wainwright estimates and price target
- Positive Sentiment: The EPA’s latest small-refinery exemption decisions are expected to reduce Calumet’s renewable identification number, or RIN, compliance liability by approximately $170 million. The potential reduction in regulatory compliance costs could support cash flow and profitability. Calumet EPA exemption update
- Positive Sentiment: Calumet’s Montana Renewables subsidiary is revising its expansion plans to increase sustainable aviation fuel production capacity to as much as 200 million gallons annually. Greater SAF capacity could improve Calumet’s long-term growth prospects, although execution and market conditions remain important. Montana Renewables SAF expansion
- Neutral Sentiment: Calumet plans to participate in the H.C. Wainwright conference, providing an opportunity for management to discuss operations, renewable fuels and its outlook with investors. Calumet conference announcement
- Neutral Sentiment: Despite H.C. Wainwright’s bullish view, the broader analyst consensus remains a “Hold,” suggesting some investors remain cautious after Calumet’s recent quarterly EPS miss.
- Negative Sentiment: Pomerantz LLP announced an investigation into potential claims on behalf of Calumet investors. The announcement does not establish wrongdoing, but it introduces potential litigation, reputational and investor-confidence risks. Pomerantz Calumet investor investigation
Wall Street Analysts Forecast Growth
A number of equities research analysts recently weighed in on CLMT shares. TD Cowen raised their target price on shares of Calumet from $34.00 to $40.00 and gave the company a “hold” rating in a research note on Wednesday, August 12th. Citigroup reissued a “buy” rating on shares of Calumet in a report on Monday, August 10th. HC Wainwright raised their price objective on shares of Calumet from $60.00 to $75.00 and gave the company a “buy” rating in a research report on Wednesday. The Goldman Sachs Group lifted their price objective on shares of Calumet from $40.00 to $45.00 and gave the stock a “neutral” rating in a report on Tuesday, August 18th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Calumet in a research report on Friday, August 7th. Two research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Calumet currently has an average rating of “Hold” and an average price target of $51.75.
Calumet Trading Up 0.1%
The company has a market cap of $4.67 billion, a P/E ratio of -34.28 and a beta of 0.72. The company’s fifty day moving average is $43.01 and its 200 day moving average is $35.91.
Calumet (NASDAQ:CLMT – Get Free Report) last posted its quarterly earnings results on Friday, August 7th. The oil and gas company reported ($1.09) earnings per share for the quarter, missing the consensus estimate of $0.07 by ($1.16). The business had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.12 billion. The firm’s revenue was up 40.8% compared to the same quarter last year. During the same period in the previous year, the company earned ($1.70) earnings per share. Analysts anticipate that Calumet, Inc. will post 0.46 EPS for the current year.
Insider Buying and Selling
In other Calumet news, Director Daniel J. Sajkowski sold 4,240 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $36.16, for a total value of $153,318.40. Following the completion of the sale, the director owned 77,718 shares in the company, valued at approximately $2,810,282.88. The trade was a 5.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 3.15% of the stock is owned by company insiders.
Institutional Investors Weigh In On Calumet
A number of large investors have recently added to or reduced their stakes in the company. Islay Capital Management LLC purchased a new stake in shares of Calumet during the fourth quarter worth about $25,000. Aster Capital Management DIFC Ltd raised its position in Calumet by 294.7% during the 4th quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company’s stock valued at $33,000 after purchasing an additional 1,229 shares during the last quarter. Global Retirement Partners LLC purchased a new stake in Calumet in the 4th quarter worth approximately $34,000. Covestor Ltd grew its position in shares of Calumet by 29.1% in the 4th quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company’s stock worth $43,000 after buying an additional 492 shares during the last quarter. Finally, Nykredit A S bought a new stake in shares of Calumet in the 2nd quarter worth approximately $57,000. Institutional investors own 34.41% of the company’s stock.
Calumet Company Profile
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.
Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.
Recommended Stories
- Five stocks we like better than Calumet
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.
